||EPS - Basic
||Market Cap (m)
|Pharmaceuticals & Biotechnology
Levrett Share Discussion Threads
Showing 151 to 174 of 175 messages
|An update on a patent grant on nuformix site news.|
|Thats a good rns.
Of course it is going ahead and 4p return.
5 million shares bought for 4p each.
Someone has faith.
And on the subject on why support nuformix!!!
Of course they will want to support them as they are aquiring them.
The business needs funding to get this tech and its patents released and a listing is the stage that nuformix find themselves at after years of patent development.
So negative Fred. Please troll on somewhere else.|
You may be right of course as AIM cos all seem to me to be risky but I fail to see anything in it for the private investor who has just put £200k into the company, if you are correct.
I hope for something better than you predict but all imho so dyor!|
|Great RNS - rubbish! A WONGA loan at 9% interest signals distress. Does this mean the LVRT has burned through the £1 million it had when it listed? Looks like it! What on earth is it doing "supporting Nuformix" prior to acquisition? Is the lending secured/guaranteed (it should be!)? Obviously, Nuformix has run out of cash (and is a cash guzzler. On any RTO a substantial amount on new money would have to be raised (= more dilution) and given Regan's reputation (or lack of it c/f CTAG) this might be a tall order...|
Great RNS imho just out reading:
Levrett, a Company formed to acquire a target company with realisable or developed commercial technologies in the pharmaceutical and biotechnology sector, announces that it has entered into a Convertible Loan Agreement for £200,000 ("Loan") with a private investor.
The Loan is for a fixed term of 12 months and carries interest at 9% per annum, which the Lender can elect to convert. The Loan is convertible into new Ordinary Shares in the Company at a price of 4 pence per share ("Conversion"), and following Conversion the Lender will be granted a one-for-one warrant to subscribe for new ordinary shares at 4 pence per share, exercisable for a period of three years from Conversion. Under the terms of the Loan, the Lender will advance the total sum to the Company within three business days.
The proceeds from the Loan are to be used for general working capital and to support Nuformix Limited in the short-term pending completion of the potential reverse takeover as announced by the Company on 16 September 2016. The acquisition remains conditional, inter alia, on consent from the UK Listing Authority for the readmission of the combined entity to the Standard List.
The 4p per share conversion price signifies some decent profit for those holding before the suspension and the whole RNS seems +ve though not certain about the RTO going ahead which presumably after all this time it would hardly be if talks were being halted.|
|This is suspended awaiting gm for aquisition to complete.|
|some ppl have been waiting 15 months in shells and still nothing...is this main market listed?|
|Over 3 months since december update.
So could be another 3 months yet !!!!|
|Shareholders should surely be entitled to an update RNS in April as that will be 6 months+ from the date of suspension.|
|I reckon this week is the week we get our news|
|Well not today jimduggen!
The suspension has lasted for c. 6months now.
I should have thought it reasonable to expect a statement/RNS soon from LVRT and/or Nuformix.|
Im sure it will go ahead.|
Assuming that the RTO takes place, my expectation is that the existing no of LVRT shares will be increased substantially but with current LVRT shareholders benefiting from the new shares in proportion to their current holdings.
Hopefully the value of the new shares will mean that existing LVRT shareholders see gains from the RTO but given that the new shares will be traded on AIM, there can be no guarantees about share price until trading commences and prospective new investors have been able
to consider the prospectus and other info on the new co.
Presumably the new co will have an new name and its shares a new EPIC.
All the above is subject to the RTO going ahead and is imho!|
|Maytrees-do you think we will have the same amount of shares on admission or an exchange like 2/1 exchange?|
|Is that losers or loosers you fool.|
|Nothing wrong with Corvus? It backs loosers - just look at the track record...|
|This is a corvus shell in biotech.
Im sure the new company will be guided by industry professionals so very little input from corvus
Nothing wrong with corvus.|
|Sirius - are you having a laugh? ASOS was 20 years ago! Name the "many others" (there aren't any!).|
|Asos, sirius amongst many others fred|
Suggest here that nuformix is a thalesnano spin off|
|What winners have Corvus promoted? Gable, Conival, Mentum, Gaming Insight, diamond Tech - all went bust!|
|Not all become winners but most corvus companys do.
Anthony reeves had little say over cloudtag imo|
LVRT shares have been suspended from trading since September 2016 pending RTO. A little difficult for those holding since then to do much else or avoid as you suggest at this time!
Shortly before the LVRT suspension the share price soared N which emabled holders to take some good profits.
Cant speak about CTAG though.|